No abstract available.
Blepharoptosis*

No abstract available.
Aspirin* ; Mucocutaneous Lymph Node Syndrome*

Discrete subaortic stenos is one of the subtype of congenital left ventricular outflow obstruction and frequently associated with other defect such as ventricular septal defect, coarctation of the aorta, inturrupted aortic arch, double-chambered right ventricle and atrioventricular canal. It is progressive disease from the neonatal period and can be a cause of secondary endocarditis or aortic regurgitation. The authors have experienced a case of discrete subaortic stenosis without other associated lesions in 8 years old male patient who has complained chest discomfort. The diagnosis was established by the findings of echocardiography and cardiac catheterization. We report this case with a brief review of related literatures.
Aorta, Thoracic ; Aortic Coarctation ; Aortic Valve Insufficiency ; Cardiac Catheterization ; Cardiac Catheters ; Child ; Diagnosis ; Discrete Subaortic Stenosis* ; Echocardiography ; Endocarditis ; Heart Septal Defects, Ventricular ; Heart Ventricles ; Humans ; Male ; Thorax ; Ventricular Outflow Obstruction

No abstract available.
Coronary Aneurysm* ; Mucocutaneous Lymph Node Syndrome*

No abstract available.
Child* ; Fatty Liver ; Humans ; Hypercholesterolemia ; Incidence* ; Obesity

Treatment of giant aneurysms of the basilar artery remains difficult and controversial. Especially, surgical treatment of the basilar trunk aneurysm have a potential morbidity or mortality due to its anatomical environment and the complicated surgical exposure. A 32-year-old female presented with an unruptured, giant basilar trunk aneurysm manifesting as brainstem compression signs and cranial nerve dysfunction. Cerebral angiography disclosed a giant aneurysm with a wide neck and an intra-aneurysmal thrombus arising from the mid-basilar artery. Aneurysm was embolized with Guglielmi detachable coils; and complete occlusion of the aneurysm was obtained.
Adult ; Aneurysm* ; Arteries ; Basilar Artery ; Brain Stem ; Cerebral Angiography ; Cranial Nerves ; Female ; Humans ; Mortality ; Neck ; Thrombosis

Cell-free nucleic acids (cf-NAs) originate in trophoblasts and are detected in the maternal plasma. Using innovative bioinformatic technologies such as next-generation sequencing, cf-NAs in the maternal plasma have been rapidly applied in prenatal genetic screening for fetal aneuploidy. Amniotic fluid is a complex and dynamic fluid that provides growth factors and protection to the fetus. In 2001, the presence of cf-NA in amniotic fluid was reported. Amniotic fluid is in direct contact with the fetus and is derived from fetal urine and maternal and fetal plasma. Therefore, these genetic materials have been suggested to reflect fetal health and provide real-time genetic information regarding fetal development. Recently, several studies evaluated the global gene expression changes of amniot ic fluid cell-free RNA according to gestational age. In addition, by analyzing the transcriptome in the amniotic fluid of fetal aneuploidy, potential key pathways and novel biomarkers for fetal chromosomal aneuploidy were identified. Here, we review the current knowledge of cell-free RNA in amniotic fluid and suggest future research directions.
Amniotic Fluid* ; Aneuploidy ; Biomarkers ; Computational Biology ; Female ; Fetal Development ; Fetus ; Gene Expression ; Gene Expression Profiling ; Genetic Testing ; Gestational Age ; Intercellular Signaling Peptides and Proteins ; Nucleic Acids ; Plasma ; Prenatal Diagnosis ; RNA* ; Transcriptome ; Trophoblasts

PURPOSE: To evaluate the effects of angiotensin-converting enzyme inhibitors (ACE-I) in retarding progression of severe non-proliferative diabetic retinopathy (NPDR) in normotensive type 2 diabetic patients. METHODS: This was a retrospective case control study of 128 patients with normotensive type 2 diabetes with lower than +1 dipstick proteinuria and severe NPDR who were classified into either an ACE-I treated group (Enalapril maleate 10 mg, n=12 , Ramipril 5 mg, n=17) or an ACE-I untreated group (n=99). Medical records were reviewed for endpoints of (a) occurrence of proliferative diabetic retinopathy (PDR) or macular edema (ME) for which laser phototherapy was necessary or (b) development of proteinuria of higher than +1 level requiring medication of ACE-I. RESULTS: From the total of 128 patients, there were 29 ACE-I treated patients and 99 ACE-I untreated patients. There were no differences in the average age, duration of diabetes, body mass indices, blood pressure and levels of hyperglycemia or HbA1C between the two groups. Blood pressure and HbA1C levels in both groups remained unchanged during the study. The mean follow-up period was 41.6 months. In the ACE-I group, 6 patients progressed to PDR, 5 to ME and 6 developed proteinuria of greater than +1 over the follow-up period. In the control group, 30 patients progressed to PDR, 6 to ME and 9 developed proteinuria of greater than +1 over the follow-up period. CONCLUSIONS: Small doses of ACE-I did not yield any beneficial effects in retarding the progression of severe NPDR.
Treatment Failure ; Severity of Illness Index ; Retrospective Studies ; Ramipril/administration & dosage/*therapeutic use ; Middle Aged ; Male ; Humans ; Fundus Oculi ; Female ; Enalapril/administration & dosage/*therapeutic use ; Dose-Response Relationship, Drug ; Disease Progression ; Diabetic Retinopathy/*drug therapy/pathology ; Diabetes Mellitus, Type 2 ; Case-Control Studies ; Angiotensin-Converting Enzyme Inhibitors/administration & dosage/*therapeutic use ; Aged

No abstract available.
Humans ; Mycoplasma pneumoniae* ; Mycoplasma* ; Pneumonia* ; Pneumonia, Mycoplasma*

No abstract available.
Burns* ; Hand* ; Humans ; Infant*